C - Michigan Technological University

More documents

Recommendations

Info

137. Nelson, R.A., T.D. Beck, and D.L. Steiger, Ratio of serum urea to serumcreatinine in wild black bears. Science, 1984. 226(4676): p. 841-2.138. Wyss, M. and R. Kaddurah-Daouk, Creatine and creatinine metabolism. PhysiolRev, 2000. 80(3): p. 1107-213.139. Salgado, J.V., et al., Monitoring renal function: measured and estimatedglomerular filtration rates - a review. Braz J Med Biol Res, epub ahead of print2010. 43(6): p. 528-36.140. Chu, P., et al., Correlation between histomorphometric parameters of boneresorption and serum type 5b tartrate-resistant acid phosphatase in uremicpatients on maintenance hemodialysis. Am J Kidney Dis, 2003. 41(5): p. 1052-9.141. Urena, P., et al., Serum pyridinoline as a specific marker of collagen breakdownand bone metabolism in hemodialysis patients. J Bone Miner Res, 1995. 10(6):p. 932-9.142. Mazzaferro, S., et al., Diagnostic value of serum peptides of collagen synthesisand degradation in dialysis renal osteodystrophy. Nephrol Dial Transplant, 1995.10(1): p. 52-8.143. Withold, W., W. Friedrich, and S. Degenhardt, Serum bone alkaline phosphataseis superior to plasma levels of bone matrix proteins for assessment of bonemetabolism in patients receiving renal transplants. Clin Chim Acta, 1997. 261(2):p. 105-15.144. Coen, G., et al., Bone markers in the diagnosis of low turnover osteodystrophy inhaemodialysis patients. Nephrol Dial Transplant, 1998. 13(9): p. 2294-302.145. Jarava, C., et al., Bone alkaline phosphatase isoenzyme in renal osteodystrophy.Nephrol Dial Transplant, 1996. 11 Suppl 3: p. 43-6.146. Delmas, P.D., Biochemical markers of bone turnover: methodology and clinicaluse in osteoporosis. Am J Med, 1991. 91(5B): p. 59S-63S.147. Urena, P. and M.C. De Vernejoul, Circulating biochemical markers of boneremodeling in uremic patients. Kidney Int, 1999. 55(6): p. 2141-56.148. Yamada, S., et al., Utility of serum tartrate-resistant acid phosphatase(TRACP5b) as a bone resorption marker in patients with chronic kidney disease:independence from renal dysfunction. Clin Endocrinol (Oxf), 2008. 69(2): p. 189-96.149. Shidara, K., et al., Serum levels of TRAP5b, a new bone resorption markerunaffected by renal dysfunction, as a useful marker of cortical bone loss inhemodialysis patients. Calcif Tissue Int, 2008. 82(4): p. 278-87.150. Kawai, M., M.J. Devlin, and C.J. Rosen, Fat targets for skeletal health. Nat RevRheumatol, 2009. 5(7): p. 365-72.146
151. Confavreux, C.B., R.L. Levine, and G. Karsenty, A paradigm of integrativephysiology, the crosstalk between bone and energy metabolisms. Mol CellEndocrinol, 2009. 310(1-2): p. 21-9.152. Lee, N.K., et al., Endocrine regulation of energy metabolism by the skeleton.Cell, 2007. 130(3): p. 456-69.153. Ferron, M., et al., Osteocalcin differentially regulates beta cell and adipocytegene expression and affects the development of metabolic diseases in wild-typemice. Proc Natl Acad Sci U S A, 2008. 105(13): p. 5266-70.154. Yamauchi, M., et al., Relationships between undercarboxylated osteocalcin andvitamin K intakes, bone turnover, and bone mineral density in healthy women.Clin Nutr, epub ahead of print 2010.155. Karbowska, J. and Z. Kochan, Role of adiponectin in the regulation ofcarbohydrate and lipid metabolism. J Physiol Pharmacol, 2006. 57 Suppl 6: p.103-13.156. Huang, C.Y., et al., Adiponectin increases BMP-2 expression in osteoblasts viaAdipoR receptor signaling pathway. J Cell Physiol, 2010. 224(2): p. 475-83.157. Lee, H.W., et al., Adiponectin stimulates osteoblast differentiation throughinduction of COX2 in mesenchymal progenitor cells. Stem Cells, 2009. 27(9): p.2254-62.158. Kanazawa, I., et al., Adiponectin and AMP kinase activator stimulate proliferation,differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol,2007. 8: p. 51.159. Lin DC, E.L., Schertenleib KW, Nelson OL, Robbins CT. Intermittent muscleactivation in grizzly bears during hibernation: a strategy to prevent muscleatrophy? in Society for Neuroscience Annual Meeting Program. 2004. San Diego,CA.160. Rubin, C., et al., Mechanical strain, induced noninvasively in the high-frequencydomain, is anabolic to cancellous bone, but not cortical bone. Bone, 2002. 30(3):p. 445-52.161. McGee, M.E.M., K.W.; Miller, D.L.; Maki, A.J.; Donahue, S.W., Despite annualperiods of disuse (hibernation), cortical bone porosity decreases and ashfraction, cross-sectional properties, and mechanical properties increase with agein black bear feumrs. Engineering Fracture Mechanics, 2007. 74: p. 1942-52.162. Emerton, K.B., et al., Osteocyte apoptosis and control of bone resorptionfollowing ovariectomy in mice. Bone, 2010. 46(3): p. 577-83.163. van Breukelen, F., G. Krumschnabel, and J.E. Podrabsky, Vertebrate cell deathin energy-limited conditions and how to avoid it: what we might learn from147
Page 1 and 2:
EXPLORATION OF THE ROLE OF SERUM FA
Page 3 and 4:
Table of contentsIndex of Figures .
Page 5 and 6:
Chapter Four - Attempts to find an
Page 7 and 8:
Index of figures1.1. Simplified sch
Page 9 and 10:
6.17. Longitudinal analysis of OPG
Page 11 and 12:
6.49. Longitudinal analysis of ColI
Page 13 and 14:
A.2. Complete list of BSALP correla
Page 15 and 16:
List of abbreviationsα-MEM. Alpha-
Page 17 and 18:
PCR. Polymerase chain reactionPer1
Page 19 and 20:
G2/M checkpoint. The point in the c
Page 21 and 22:
Species names13-lined ground squirr
Page 23 and 24:
Chapter One - Background and signif
Page 25 and 26:
1.3 Bone turnover is unbalanced dur
Page 27 and 28:
pro-apoptosis regulator BAX. An imp
Page 29 and 30:
low-dose administration of parathyr
Page 31 and 32:
decrease in bone trabecular thickne
Page 33 and 34:
experience periodic arousals in whi
Page 35 and 36:
ears must have evolved a mechanism
Page 37 and 38:
1.7.6 Hypothesis 2: OCN interacts w
Page 39 and 40:
ain, heart, and femoral muscle of h
Page 41 and 42:
Hypothesis 3a: Serum concentrations
Page 44:
were released. Behavior indicating
Page 47 and 48:
2.3 ResultsSerum activity of the bo
Page 49 and 50:
(p
Page 51 and 52:
post-hibernation sampling in the be
Page 53 and 54:
also unclear whether ucOCN may affe
Page 55 and 56:
atios of intact to fragmented OCN m
Page 57 and 58:
Table 2.3—Bone marker “seasonal
Page 59 and 60:
Table 2.7—Chemistry panel “seas
Page 61 and 62:
ABNormalized BSALPBSALP (U/L)CO N D
Page 63 and 64:
Total Calcium (mg/dL)A1.21.151.11.0
Page 65 and 66:
ABTotal OCN (ng/mL)150100500O N D J
Page 67 and 68:
Adiponectin (ng/mL)AB40003500300025
Page 69 and 70:
ABNormalized InsulinInsulin (μU/mL
Page 71 and 72:
surrounding and encompassing hibern
Page 73 and 74:
decreased from 788+30 ng/mL in preh
Page 75 and 76:
120-122]. Most small hibernators ar
Page 77 and 78:
ears. Similarly, serum NPY increase
Page 79 and 80:
Table 3.2—Serum factor longitudin
Page 81 and 82:
Leptin (ng/mL)ABO N D J F M A M O N
Page 83 and 84:
Norepinephrine (ng/mL)A807060504030
Page 85 and 86:
IGF‐1 (ng/mL)AN D J F M A MB10009
Page 87 and 88:
2008. Samples were collected as des
Page 89 and 90:
sampling points. It is possible to
Page 91 and 92:
C‐Terminal PTH (Relative)AB504030
Page 93 and 94:
Chapter Five — Serum from hiberna
Page 95 and 96:
Synergy HT Multi-Detection Micropla
Page 97 and 98:
gene specific primers and 12.5 μL
Page 99 and 100:
involved in the reduced caspase-3/7
Page 101 and 102:
hibernation cycles without problem
Page 103 and 104:
filtered seasonal bear serum and fo
Page 105 and 106:
which is dependent upon caspase-3 a
Page 107 and 108:
Caspase‐3/7 ActivityO N D J F M A
Page 109 and 110:
6Caspase‐3/7 Activity54321**0Vehi
Page 111 and 112:
ABCaspase‐3/7 Activity9876543210*
Page 113 and 114:
eyond the G1/S checkpoint, thus ind
Page 115 and 116:
ears, it is possible that tissue se
Page 117 and 118: PTH1R, RANKL, Runx2, Smurf1, TLR4,
Page 119 and 120: factors Runx2 and OCN also increase
Page 121 and 122: Table 6.3—Gene expression 3 hour
Page 123 and 124: Table 6.5—Gene expression 6 day d
Page 125 and 126: Cyclin D1 Gene ExpressionO N D J F
Page 127 and 128: Smurf1 Gene ExpressionO N D J F M A
Page 129 and 130: BAK Gene ExpressionO N D J F M A MM
Page 131 and 132: M‐CSF Gene ExpressionO N D J F M
Page 133 and 134: Per1 Gene ExpressionO N D J F M A M
Page 135 and 136: Akt Gene ExpressionO N D J F M A MM
Page 137 and 138: Bcl‐2 Gene ExpressionO N D J F M
Page 139 and 140: Cyclin D1 Gene ExpressionO N D J F
Page 141 and 142: OPN Gene ExpressionO N D J F M A MM
Page 143 and 144: 2PTH1R Gene Expression1.510.50O N D
Page 145 and 146: TLR4 Gene ExpressionO N D J F M A M
Page 147 and 148: Bcl‐2 Gene ExpressionO N D J F M
Page 149 and 150: OCN Gene ExpressionO N D J F M A MM
Page 151 and 152: PTH1R Gene ExpressionO N D J F M A
Page 153 and 154: TLR4 Gene ExpressionO N D J F M A M
Page 155 and 156: condition in renal patients in whic
Page 157 and 158: hibernation. This report brings to
Page 159 and 160: 14. Kaneps, A.J., S.M. Stover, and
Page 161 and 162: 41. Chowdhury, I., B. Tharakan, and
Page 163 and 164: 68. Ashe, M.C., et al., Bone geomet
Page 165 and 166: 95. Perrien, D.S., et al., Aging al
Page 167: 122. Lesser, R.W., et al., Renal re
Page 171 and 172: 178. Toribara, T.Y., A.R. Terepka,
Page 173 and 174: 206. Luo, X.H., et al., Adiponectin
Page 175 and 176: 233. Florant, G.L., et al., Fat-cel
Page 177 and 178: 259. Bhasin, S., et al., Older men
Page 179 and 180: 284. Miura, M., et al., A crucial r
Page 181 and 182: Appendix A—Complete tables of cor
Page 183 and 184: Table A.5—Complete list of ionize
Page 185 and 186: Table A.7—Complete list of adipon
Page 187 and 188: Table A.12—Complete list of norep
show all

C - Michigan Technological University

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?